Novo Nordisk
Silas Hinsch Gylvin is a seasoned medical professional with extensive experience in the pharmaceutical and medical education sectors. Currently serving as Medical Director at Ascendis Pharma since April 2023, Silas previously held the position of Senior International Medical Manager at Novo Nordisk from May 2018 to April 2023, specializing in medical and scientific aspects of GLP-1, cardiovascular, and outcomes research. Silas's academic background includes a Doctor of Philosophy degree in Medicine, obtained from the University of Copenhagen, and a Cand. Med. degree, also from the University of Copenhagen. Additional experiences include roles as an Instructor at the Copenhagen Academy for Medical Education and Simulation and various medical positions across hospitals specializing in internal medicine, vascular surgery, and orthopedic surgery.
This person is not in any teams
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.